Singapore markets closed
Straits Times Index
3,297.55 -26.98 (-0.81%) Nikkei
38,814.56 +94.09 (+0.24%) Hang Seng
17,941.78 -170.85 (-0.94%) FTSE 100
8,146.86 -16.81 (-0.21%) Bitcoin USD
66,242.54 +30.84 (+0.05%) CMC Crypto 200
1,373.70 -44.18 (-3.12%)
Hikma Pharmaceuticals PLC (H5P.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 09:50PM CEST
| Previous close | 23.60 |
| Open | 23.60 |
| Bid | 23.20 x N/A |
| Ask | 23.60 x N/A |
| Day's range | 23.20 - 23.60 |
| 52-week range | 19.70 - 25.60 |
| Volume | |
| Avg. volume | 2 |
| Market cap | 5.16B |
| Beta (5Y monthly) | 0.41 |
| PE ratio (TTM) | 29.37 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.67 (2.89%) |
| Ex-dividend date | 21 Mar 2024 |
| 1y target est | N/A |
- Simply Wall St.
An Intrinsic Calculation For Hikma Pharmaceuticals PLC (LON:HIK) Suggests It's 35% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, Hikma Pharmaceuticals fair value estimate is UK£29.89 Hikma...
- Simply Wall St.
With 52% institutional ownership, Hikma Pharmaceuticals PLC (LON:HIK) is a favorite amongst the big guns
Key Insights Significantly high institutional ownership implies Hikma Pharmaceuticals' stock price is sensitive to...
- Simply Wall St.
Optimism around Hikma Pharmaceuticals (LON:HIK) delivering new earnings growth may be shrinking as stock declines 3.3% this past week
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...
© 2024 Yahoo. All rights reserved.